Physician profile
Millard Andrew Davis
NPI 1790073872
$907.75
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2024: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $366 · Food and Beverage: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $365.59 |
| Food and Beverage | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $430.59 | 2024 | |
| Davol INC. | $242.06 | 2019 | |
| Portola Pharmaceuticals, LLC | $63.89 | 2019 | |
| Pfizer INC. | $55.22 | 2019 | |
| Z-Medica, LLC | $44.94 | 2019 | |
| Prytime Medical Devices, INC. | $31.84 | 2019 | |
| Acell, INC. | $20.47 | 2019 | |
| Smith+Nephew, INC. | $18.74 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Millard Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.